Advanced Provision of Care

Oregon Health & Science University (OHSU)

Status

Completed

Conditions

Pregnancy Related

Treatments

Other: Telehealth Visit

Study type

Interventional

Funder types

Other

Identifiers

NCT05848908

STUYD00025095

Details and patient eligibility

About

This study aims to evaluate advanced provision of an anti-progestin with a prostaglandin for future use (in the next 12 months) in individuals at risk for pregnancy but not desiring a pregnancy.

Full description

The purpose of this study is to learn more about counseling via telemedicine and advanced provision of medications to individuals at risk for pregnancy but before they are pregnant. If they experience this event, then they may subsequently have immediate access to the care they need plus an established connection with a health provider.

Enrollment

50 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

18 to 40 years old at time of consent
Anatomically capable of pregnancy
Self-reported a history of regular menses (>24 and <38 days) in the past 3 years (other than during pregnancy)
Not currently pregnant and not desiring to be pregnant in the next year
Say they would seek to end the pregnancy if they became pregnant in the next year and who do not express a preference for an in office procedure
At-risk for unintended pregnancy defined as:
those who report being sexually active (vaginal sex with partners with sperm)
have not been told by a clinician that they cannot become pregnant
have not had a permanent contraception procedure and whose current sexual partner(s) has not had a permanent contraception procedure
who are not using a long-acting reversible contraceptive (LARC)
Willing and able to provide informed consent
Willing/able to receive phone calls from study staff and complete electronic surveys distributed by EMR or email
Planning to live within the state of Oregon or Washington for the 12 month study period.

Exclusion criteria

Less than 18 and older than 40 years old at the time of consent
Any medical contraindications to MAB (hemorrhagic disorder or will be taking anticoagulants during study period, chronic adrenal failure or will be taking long term corticosteroids >1 week during study period, inherited porphyria, or an allergy to mifepristone or misoprostol)
Currently pregnant or desiring pregnancy in the next year
State they would not seek to end a pregnancy if they became pregnant in the next year or who express a preference for an in office procedure
History of ectopic pregnancy